CAS: 170277-31-3 - Immunoglobulin G, anti-(human tumor necrosis factor), (human-mouse monoclonal cA2 heavy chain), disulfide with human-mouse monoclonal cA2 light chain, dimer
Formula:Unspecified
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Infliximab CRS REF: 41-Y0002047CAS: 170277-31-3 | - - - | 115.00 € | Thu 05 Dec 24 |
 | Infliximab (10 mg/ml) REF: 3D-FI139130CAS: 170277-31-3 | Min. 95% | 452.00 €~1,945.00 € | Wed 18 Dec 24 |
 | Infliximab REF: TM-T9921CAS: 170277-31-3 | 98% - 99.70% | 95.00 €~1,208.00 € | Mon 27 Jan 25 |
Ref: 41-Y0002047
| 100mg | 115.00 € |
Estimated delivery in United States, on Thursday 5 Dec 2024
Infliximab (10 mg/ml)
CAS:170277-31-3
Infliximab is a chimeric monoclonal antibody against tumor necrosis factor-alpha (TNF-α). It binds to the …
Purity:
Min. 95%
Color and Shape:
Powder
Ref: 3D-FI139130
| 5mg | 452.00 € | ||
| 10mg | 633.00 € | ||
| 25mg | 861.00 € | ||
| 50mg | 1,296.00 € | ||
| 100mg | 1,945.00 € |
Estimated delivery in United States, on Wednesday 18 Dec 2024
Infliximab
CAS:170277-31-3
Infliximab is a chimeric monoclonal antibody that inhibits TNF-α. Infliximab can be used to treat …
Purity:
98% - 99.70%
Color and Shape:
Liquid
Molecular weight:
149 kDa
Ref: TM-T9921
| 1mg | 95.00 € | ||
| 2mg | 157.00 € | ||
| 5mg | 254.00 € | ||
| 25mg | 626.00 € |
Estimated delivery in United States, on Monday 27 Jan 2025
